Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma
- Toni K. Choueiri
- , Mayer N. Fishman
- , Bernard Escudier
- , David F. McDermott
- , Charles G. Drake
- , Harriet Kluger
- , Walter M. Stadler
- , Jose Luis Perez-Gracia
- , Douglas G. McNeel
- , Brendan Curti
- , Michael R. Harrison
- , Elizabeth R. Plimack
- , Leonard Appleman
- , Lawrence Fong
- , Laurence Albiges
- , Lewis Cohen
- , Tina C. Young
- , Scott D. Chasalow
- , Petra Ross-Macdonald
- , Shivani Srivastava
- Brigham and Women's Hospital
- University of South Florida
- Université Paris-Sud
- Beth Israel Deaconess Medical Center
- Johns Hopkins University
- Yale University
- University of Chicago
- University of Navarra
- University of Wisconsin-Madison
- Earle A. Chiles Research Institute
- Duke University
- University of Pittsburgh
- University of California at San Francisco
- Dana-Farber Cancer Institute
- Bristol-Myers Squibb
- Johnson & Johnson
- AstraZeneca
Research output: Contribution to journal › Article › peer-review
253
Scopus
citations